BioXcel Therapeutics BTAI
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.60 | -95 | -13 | -27.97 | 45 | |
| 2025Q3 | 2.56 | -89 | -31 | -87.59 | 45 | |
| 2025Q2 | 1.81 | -108 | -19 | -59.63 | 26 | |
| 2025Q1 | 2.03 | -90 | -7 | -18.87 | 39 | |
| 2024Q4 | 5.98 | -93 | -11 | -24.90 | 38 | |
| 2024Q3 | 9.76 | -86 | -14 | -23.88 | 49 | |
| 2024Q2 | 20.48 | -74 | -8 | -11.23 | 65 | |
| 2024Q1 | 45.12 | -72 | -27 | -34.34 | 82 | |
| 2023Q4 | 47.20 | -57 | -22 | -25.56 | 74 | |
| 2023Q3 | 40.48 | -41 | -50 | -41.98 | 100 | |
| 2023Q2 | 106.56 | 6 | -181.81 | -54 | -33.43 | 140 |
| 2023Q1 | 298.56 | 53 | -81.36 | -53 | -27.36 | 180 |
| 2022Q4 | 343.68 | 77 | -53.80 | -55 | -24.32 | 206 |
| 2022Q3 | 189.12 | 127 | -28.71 | -42 | -16.96 | 245 |
| 2022Q2 | 211.20 | 164 | -21.03 | -38 | -16.40 | 248 |
| 2022Q1 | 334.56 | 194 | -15.14 | -31 | -13.97 | 211 |
| 2021Q4 | 325.28 | 222 | -11.18 | -26 | -10.43 | 239 |
| 2021Q3 | 485.60 | 246 | -10.45 | -27 | -9.89 | 261 |
| 2021Q2 | 464.96 | 267 | -12.16 | -28 | -11.47 | 281 |
| 2021Q1 | 690.56 | 187 | -13.41 | -26 | -12.55 | 200 |